BFFTF News and Press, Biofrontera AG

2024-03-18 00:39:34 ET More on Biofrontera Biofrontera stock soars on announcing private placement of up to $16M Seeking Alpha’s Quant Rating on Biofrontera Historical earnings data for Biofrontera Financial information for Biofrontera Read t...

2023-08-11 07:07:52 ET Biofrontera press release ( NASDAQ: BFRI ): Q2 GAAP EPS of -$7.23 misses by $2.62 . Revenue of $5.8M (+31.0% Y/Y) misses by $0.38M . Adjusted EBITDA for the second quarter of 2023 was negative $7.9 million compared with negative $7.1 mill...

Biofrontera is eyeing significant growth opportunities for its FDA-approved skin disease photodynamic therapy drug "Ameluz". Updates regarding several ongoing clinical studies for expanded label indications can be a catalyst for the stock in 2022. While Biofrontera maintains a pos...

The following slide deck was published by Biofrontera AG in conjunction with this event. For further details see: Biofrontera (BFRA) Investor Presentation - Slideshow

Biofrontera AG (BFRA) Q3 2021 Earnings Conference Call November 18, 2021, 08:00 AM ET Company Participants Pamela Keck - Head, IR Hermann Lübbert - CEO Ludwig Lutter - CFO Conference Call Participants Bruce Jackson - Benchmark Company Thomas Flaten - Lake Street Capital Markets Presentat...

Biofrontera AG (BFRA) Q2 2021 Earnings Conference Call August 20, 2021, 8:00 AM ET Company Participants Pamela Keck - Head, Investor Relations Hermann Lübbert - Chief Executive Officer Ludwig Lutter - Chief Financial Officer Conference Call Participants Bruce Jackson - The Benchmark Comp...

Biofrontera Inc. is presently a wholly owned U.S. subsidiary of Biofrontera AG (BFRA). The company sells FDA-approved photodynamic therapy and topical antibiotics as an exclusive licensee. The company has exclusive license to market additional indications. For further detail...

Biofrontera AG (BFRA) Q4 2020 Earnings Conference Call April 13, 2021 08:00 AM ET Company Participants Pamela Keck - Head, Investor Relations Hermann Lübbert - Chief Executive Officer Ludwig Lutter - Chief Financial Officer Conference Call Participants Bruce Jackson - The Benchmark Compa...

Biofrontera AG (BFRA) Q2 2020 Earnings Conference Call August 27, 2020 08:00 AM ET Company Participants Pamela Keck - Head, Investor Relations Hermann Lübbert - Chief Executive Officer Thomas Schaffer - Chief Financial Officer Conference Call Participants Thomas Flaten...

Biofrontera AG (BFRA) Q1 2020 Results Earnings Conference Call May 20, 2020 8:00 AM ET Company Participants Pamela Keck - Head, Investor Relations Hermann Lübbert - Chief Executive Officer Thomas Schaffer - Chief Financial Officer Conference Call Participants Bruce J...